zidovudine has been researched along with Esophageal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; He, Q; Liu, Y; Wang, H; Zhou, J | 1 |
| Chen, X; Cheng, Y; Guan, S; Han, L; Liu, Y; Wang, C | 1 |
2 other study(ies) available for zidovudine and Esophageal Neoplasms
| Article | Year |
|---|---|
Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer.
Topics: Cell Line, Tumor; Cell Proliferation; DNA Damage; Enzyme Activation; Esophageal Neoplasms; Humans; M Phase Cell Cycle Checkpoints; Telomerase; Zidovudine | 2017 |
Zidovudine, abacavir and lamivudine increase the radiosensitivity of human esophageal squamous cancer cell lines.
Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Dideoxynucleosides; DNA Damage; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Lamivudine; Radiation Tolerance; Radiation-Sensitizing Agents; Telomerase; Telomere; Zidovudine | 2016 |